CHD Risk Increases in Diabetes with Aggressive Blood Pressure Control
MedicalResearch.com Interview Invitation Dr. Gang Hu, MD, PHD Pennington Biomedical Research Center, Baton Rouge, Louisiana MedicalResearch.com: What are the main findings of...
MedicalResearch.com Interview Invitation Dr. Gang Hu, MD, PHD Pennington Biomedical Research Center, Baton Rouge, Louisiana MedicalResearch.com: What are the main findings of...
MedicalResearch.com Interview with: Lilian Abbo, M.D. Associate Professor of Clinical Medicine Division of Infectious Diseases University of Miami Miller School of Medicine Medical Director...
From: Duke University
Department of Psychology & Neuroscience, Institute for Genome Sciences & Policy 2020 West Main Street, Suite 201 Box 104410 Durham, North Carolina 27708
TITLE: Retinal Vessel Caliber and Lifelong Neuropsychological Functioning An international research team from the USA, UK, Singapore and New Zealand reports that the size of the blood vessels in the back of the eye can indicate the health of the brain of people approaching midlife (age 38 years), years before age-related declines in brain functioning. PUBLICATION SOURCE: Psychological Science, advance online publication date, May 2013. BACKGROUND:MedicalResearch.com eInterview with:
Fengcai Zhu
Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, Jiangsu provincial center for disease prevention and control
MedicalResearch.com Editor's Note: HFMD = Hand Foot and Mouth Disease
MedicalResearch.com: What are the main findings of the study? Answer: From this trial, the inactivated alum-adjuvant EV71 vaccine showed a good protection for both the EV71-associated HFMD and EV71-associated disease. The vaccine gave 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease (including neurological complications) for at least 12 months. The safety profile and immunogenicity of this vaccine is proved to be clinical acceptable. We also proposed a titre (1:32) of neutralization antibody as surrogate of protection against EV71-associated disease.MedicalResearch.com eInterview with David Melzer, MBBCH, PhD Professor of Epidemiology and Public Health Medical School - University of Exeter, Barrack Road, Exeter EX2...
MedicalResearch.com eInterview with Muhammad Mamdani Director, Applied Health Research Centre, St. Michael's Hospital Scientist in the Keenan Research Centre of the Li...